In this accelerating and all-consuming digital age, what can we anticipate from global healthcare organizations and pharmaceutical manufacturers in the next decade? Can digital tools alter, augment, or improve drug-delivery schema? Could digital assets emerge as actual (and powerful) new drug types in their own right? Might, or must, ‘digital pharmaceuticals’ be labeled, like film or TV ratings, even by the neurotransmitters that they trigger? Are Facebook and Pfizer on a collision course, and will we witness the regulation of social media, as per Mark Benioff’s suggestion, that we treat it in a manner reminiscent of Big Tobacco?
Drawing from science fiction and its prescient glimpses of the near-future (Philip K Dick, William Gibson), highly cited peer-reviewed literature in psychology and neuroscience, plus experiments in the market (from startups and publicly traded companies), Betaworks and AeBeZe Labs endeavor to develop a richer portrait of the emerging field, and imminent future, of digital drugs.